SCOPUS 정보 검색 플랫폼

Clinical Trials

Volumn 7, Issue 5, 2010, Pages 537-545

A threshold sample-enrichment approach in a clinical trial with heterogeneous subpopulations

(5) Liu, Aiyi a Liu, Chunling a Li, Qizhai b Yu, Kai F a Yuan, Vivian W c

a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT (United States)

b CHINESE ACADEMY OF SCIENCES (China)

c CENTER FOR DRUG EVALUATION AND RESEARCH (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM;

CLINICAL STUDY; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; FEASIBILITY STUDY; HUMAN; NULL HYPOTHESIS; OUTCOME ASSESSMENT; PREECLAMPSIA; PRIORITY JOURNAL; SAMPLE SIZE; SAMPLING; SIMULATION; TREATMENT OUTCOME; TWO STAGE SAMPLE ENRICHMENT DESIGN;

HUMANS; MODELS, STATISTICAL; PATIENT SELECTION; PROBABILITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SAMPLE SIZE; STATISTICS AS TOPIC; TREATMENT OUTCOME;

EID: 78649932251 PISSN: 17407745 EISSN: 17407753 Source Type: Journal
DOI: 10.1177/1740774510378695 Document Type: Conference Paper

Times cited : (38)

References (8)

1
- 4644225190
- Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer
- Doxil study 3049 investigators
- Gordon AN, Tonda M., Sun S., Rackoff W. Doxil study 3049 investigators. Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer. Gynecol Oncol 2004 ; 95: 1-8.
- (2004) Gynecol Oncol , vol.95 , pp. 1-8
- Gordon, A.N.¹ Tonda, M.² Sun, S.³ Rackoff, W.⁴

2
- 34547529442
- A method for testing a prespecified subgroup in clinical trials
- Song Y., Chi GYH. A method for testing a prespecified subgroup in clinical trials. Stat Med 2007 ; 26: 3535-49.
- (2007) Stat Med , vol.26 , pp. 3535-49
- Song, Y.¹ Chi, G.Y.H.²

3
- 0031322659
- Adaptively changing subgroup proportions in clinical trials
- Follmann D. Adaptively changing subgroup proportions in clinical trials. Stat Sinica 1997 ; 7: 1085-1102.
- (1997) Stat Sinica , vol.7 , pp. 1085-1102
- Follmann, D.¹

4
- 0028104735
- Prevention and treatment of hypertension study (PATHS): Rationale and design
- Cushman WC, Cutler JA, Bingham SF, et al. Prevention and treatment of hypertension study (PATHS): Rationale and design. Am J Hypertension 1994 ; 7: 814-23.
- (1994) Am J Hypertension , vol.7 , pp. 814-23
- Cushman, W.C.¹ Cutler, J.A.² Bingham, S.F.³

5
- 4444345588
- Two-stage adaptive strategy for superiority and non-inferiority hypotheses in active controlled clinical trials
- Shih WJ, Quan H., Li G. Two-stage adaptive strategy for superiority and non-inferiority hypotheses in active controlled clinical trials. Stat Med 2004 ; 23: 2781-98.
- (2004) Stat Med , vol.23 , pp. 2781-98
- Shih, W.J.¹ Quan, H.² Li, G.³

6
- 25444474448
- A review of methods for futility stopping based on conditional power
- Lachin JM A review of methods for futility stopping based on conditional power. Stat Med 2005 ; 24: 2747-64. 7. Levine RJ, Esterlitz JR, Raymond EG, et al. Trial of calcium for preeclampsia prevention (CPEP): Rationale, design, and methods. Control Clin Trials 1996 ; 17: 442-69.
- (2005) Stat Med , vol.24 , pp. 2747-64
- Lachin, J.M.¹ Levine, R.J.² Esterlitz, J.R.³ Raymond, E.G.⁴

7
- 0030803395
- Trial of calcium to prevent preeclampsia
- Levine RJ, Hauth JC, Curet LB, et al. Trial of calcium to prevent preeclampsia. N Engl J Med 1997 ; 337: 69-76.
- (1997) N Engl J Med , vol.337 , pp. 69-76
- Levine, R.J.¹ Hauth, J.C.² Curet, L.B.³

8
- 0033619169
- A unified theory for sequential clinical trials
- Whitehead J. A unified theory for sequential clinical trials. Stat Med 1999 ; 18: 2271-86.
- (1999) Stat Med , vol.18 , pp. 2271-86
- Whitehead, J.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.